CEREVEL THERAPEUTICS HOLDINGS, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of August 16, 2022 2.50% Convertible Senior Notes due 2027Indenture • August 16th, 2022 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of August 16, 2022, between Cerevel Therapeutics Holdings, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
